Christina (Tina) P: Help Advance Research and Support Patients with Antiphospholipid Syndrome
Christina (Tina) P., CEO and Co-Founder of APS Foundation of America, shared on LinkedIn:
”Antiphospholipid Syndrome (APS) is an autoimmune disorder where your immune system mistakenly attacks proteins in your blood, making it clot more easily.
This can lead to serious health problems like blood clots in veins and arteries (deep vein thrombosis, pulmonary embolism), strokes, heart attacks, and repeated miscarriages or stillbirths.
It can affect anyone, though it’s more common in women and often diagnosed between ages 20 and 40.
Here’s why donating to the APS Foundation of America, Inc. is so important:
The APS Foundation of America is dedicated to supporting both adult and pediatric research into APS. In 2025, they awarded three $10,000 microgrants to research teams and $10,000 to ICAPA. They also aim to set aside 10% of donations for future research funding.
Education and Awareness: They provide vital information and education about APS to patients, their families, and the general community.
This includes information on diagnosis, symptoms, treatment, and coping.
They also work to raise national awareness for APS, which is the leading cause of stroke in young people and a significant factor in recurrent miscarriages.
The APS Foundation of America offers support and resources for those living with APS, including a network of doctors familiar with the condition and an online forum for communication with other patients.
They advocate for earlier diagnosis and better patient care.
Founded in 2005, the APS Foundation of America is a volunteer-run 501(c)(3) public charity.
They strive to keep administrative costs low, with many members being patients themselves.
They also aim for transparency, with a Charity Navigator score of 98% for accountability and finance.
Your donations help the APS Foundation of America continue its crucial work in fighting this often-misunderstood illness, advancing research, and supporting those affected.
Corporate Donations message us.”
Stay updated with Hemostasis Today.
-
Apr 25, 2026, 11:44Ruiming Li: Why the COMBO Plus form is a Masterclass in Vascular Repair
-
Apr 25, 2026, 11:19Nathan Connell: Bleeding Risk Is Not Limited to Delivery
-
Apr 25, 2026, 11:14Rashad Mohamed: What Does ‘Capping’ Mean in Anticoagulant Dosing?
-
Apr 25, 2026, 11:07Anne de Vaan: The Results of the PRIDES Study Are Now Available
-
Apr 25, 2026, 10:50Flora Peyvandi: Proteomic Insights of Relapse Risk in Thrombotic Thrombocytopenic Purpura
-
Apr 25, 2026, 10:40Kalyan Roy: Effect of Irradiation on Red Blood Cells
-
Apr 25, 2026, 10:38David Sinclair: How are High Omega-3 Levels Linked to Low Mortality Risk
-
Apr 25, 2026, 10:26Melissa Hollo: How HerCare Utilizes Hierarchical Algorithm of Severe Maternal Morbidity
-
Apr 25, 2026, 10:05Lutz Knabe: One Child’s Journey from Pain to Hope Beyond Severe Bleeding Disorder